Mutations in SPINK5, encoding a serine protease inhibitor, cause Netherton syndrome
Top Cited Papers
- 1 June 2000
- journal article
- Published by Springer Science and Business Media LLC in Nature Genetics
- Vol. 25 (2), 141-142
- https://doi.org/10.1038/75977
Abstract
We describe here eleven different mutations in SPINK5, encoding the serine protease inhibitor LEKTI, in 13 families with Netherton syndrome (NS, MIM256500). Most of these mutations predict premature termination codons. These results disclose a critical role of SPINK5 in epidermal barrier function and immunity, and suggest a new pathway for high serum IgE levels and atopic manifestations.Keywords
This publication has 14 references indexed in Scilit:
- Localization of the Netherton Syndrome Gene to Chromosome 5q32, by Linkage Analysis and Homozygosity MappingAmerican Journal of Human Genetics, 2000
- Variation in the Interleukin 4–Receptor α Gene Confers Susceptibility to Asthma and Atopy in Ethnically Diverse PopulationsAmerican Journal of Human Genetics, 2000
- Loss-of-function mutations in the cathepsin C gene result in periodontal disease and palmoplantar keratosisNature Genetics, 1999
- IgE in asthma and atopy: cellular and molecular connectionsJCI Insight, 1999
- LEKTI, a Novel 15-Domain Type of Human Serine Proteinase InhibitorPublished by Elsevier BV ,1999
- Altered Lamellar Body Secretion and Stratum Corneum Membrane Structure in Netherton SyndromeArchives of Dermatology, 1999
- RNA surveillance: unforeseen consequences for gene expression, inherited genetic disorders and cancerTrends in Genetics, 1999
- Inhibition of NF-κB Activation and Augmentation of IκBβ by Secretory Leukocyte Protease Inhibitor during Lung InflammationThe American Journal of Pathology, 1999
- Activation of the Heat Shock Factor 1 by Serine Protease InhibitorsPublished by Elsevier BV ,1998
- ECM and Cell Surface Proteolysis: Regulating Cellular EcologyCell, 1997